Campbell's Company is expected to release Q3 earnings on Monday, with analysts anticipating EPS of $0.66, down from $0.75 year-over-year, and revenue of $2.43 billion, up from $2.37 billion. Recent analyst ratings have been mixed, with several firms adjusting price targets downward, including Wells Fargo reducing its target to $34 and JP Morgan downgrading the stock to Neutral with a target of $37 following a Q2 sales miss.
Campbell's Company (CPB) is scheduled to announce its third-quarter financial results, with analysts anticipating earnings per share (EPS) of $0.66, a decline from the $0.75 reported in the same quarter of the previous year. Conversely, quarterly revenue is projected to reach $2.43 billion, an increase from $2.37 billion year-over-year. This outlook follows the company's second-quarter performance, where sales grew 9% to $2.685 billion but fell short of the $2.74 billion analyst consensus estimate. CPB's stock recently closed at $34.04, reflecting a minor 0.4% decrease. Analyst sentiment has trended towards caution: Wells Fargo maintained an Equal-Weight rating and reduced its price target from $40 to $34 on May 30, 2025; Piper Sandler, while maintaining an Overweight rating, lowered its price target from $45 to $42 on May 23, 2025; Morgan Stanley initiated coverage with an Equal-Weight rating and a $40 price target on March 24, 2025; JP Morgan downgraded the stock to Neutral from Overweight, cutting its target from $48 to $37 on March 6, 2025; and Jefferies maintained a Hold rating, slashing its target from $42 to $40 on March 5, 2025. These actions, characterized by price target reductions and cautious or downgraded ratings, contribute to a moderately negative sentiment surrounding the stock ahead of its earnings release.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment
